Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B8GI
|
||||
Former ID |
DNC011878
|
||||
Drug Name |
5-Heptyl-5-phenyl-imidazolidine-2,4-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H22N2O2
|
||||
Canonical SMILES |
CCCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2
|
||||
InChI |
1S/C16H22N2O2/c1-2-3-4-5-9-12-16(13-10-7-6-8-11-13)14(19)17-15(20)18-16/h6-8,10-11H,2-5,9,12H2,1H3,(H2,17,18,19,20)
|
||||
InChIKey |
UKJJKBMGJSMVEV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Voltage-gated sodium channel subunit alpha Nav1.3 | Target Info | Inhibitor | [1] | |
Sodium channel | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins | ||||
References | |||||
REF 1 | J Med Chem. 1999 May 6;42(9):1537-45.Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.